由于神经损伤风险,澳大利亚将从2027年6月起限制高剂量维生素B6补充剂。 Australia will restrict high-dose vitamin B6 supplements from June 2027 due to nerve damage risks.

澳大利亚将从2027年6月起限制高剂量维生素B6补充剂,要求药剂师就每日50至200毫克的产品提供咨询,并开出剂量超过200毫克的处方。 Australia will restrict high-dose vitamin B6 supplements starting June 2027, requiring pharmacist advice for products with 50–200mg daily and a prescription for doses over 200mg. 治疗物品管理局(TGA)援引了100多起关于神经损伤和其他严重健康影响的报告,包括剂量低于50毫克的病例,这促使采取了更严格的控制措施。 The Therapeutic Goods Administration (TGA) cited over 100 reports of nerve damage and other serious health effects, including cases at doses below 50mg, prompting stricter controls. 大约125种产品将受到影响,担心标签不明确,以及诸如镁和Ashwagandha等添加剂的累积暴露。 About 125 products will be affected, with concerns over unclear labeling and cumulative exposure from supplements like magnesium and ashwagandha. 虽然大多数人通过饮食获得足够的B6,但毒性病例的增加导致人们呼吁降低阈值,尽管TGA的新规则没有达到某些倡导者的要求。 While most people get enough B6 through diet, rising toxicity cases have led to calls for lower thresholds, though the TGA’s new rules fall short of some advocates’ demands.